-
Lace up your sneakers and join ZERO on Sept. 27 in Alexandria, VA for the Abbot and Depend Dash for Dad, a 10K race to support ZERO's mission to end prostate cancer. All proceeds from the race will go to prostate research and free testing in the Washington, D.C. area to those at risk.
-
DEPEND® AND ZERO
TOGETHER WE CAN HELP END PROSTATE CANCER.Kimberly-Clark’s DEPEND® brand is partnering with ZERO - The Project to End Prostate Cancer for a prostate health awareness campaign designed to educate men about the risks associated with prostate cancer.
DEPEND® is donating $250,000 to ZERO - The Project to End Prostate Cancer.*
*DEPEND® Brand is donating $250,000 through 2010.
Learn more about "The Depend Campaign to End Prostate Cancer."
-
It's free. No appointments. No insurance needed. And best of all, we come to you! It's the way every doctor's office ought to be.
-
Join ZERO and Syracuse University head basketball coach Jim Boeheim for the 2009 Know Your Score Celebrity Golf Invitational on August 29 in Myrtle Beach.
What is ZERO
ZERO is zero prostate cancer deaths, zero prostate cancer cases and for those with the disease, a zero PSA
What ZERO Does
ZERO News
- ZERO Press Releases... more
ZERO Outraged Docs Fail to Present Solution in PSA Crisis A new study of the effectiveness and cost of the PSA test for prostate cancer is yet another claim prostate cancer screening has little to no value in lowering the death rate.... more
Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' With prostate cancer affecting a staggering one in six men and 192,000 men expected to be diagnosed this year in the... more
Team ZERO to Run to End Prostate Cancer in 2009 ING New York City Marathon Spring is in the air across the country and runners are hitting the pavement to ramp up their running regimes in preparation for upcoming races... more
Prostate Cancer News
- Prostate Cancer in the News... more
- 08.17.09 - UPDATE 1-Dendreon Corp Expects Provenge to Overtake Chemo Dendreon Corp (DNDN.O) on Monday said it expects quick success for its Provenge prostate cancer treatment if it is approved by U.S. regulators... more
- 08.16.09 - Obese Blacks and Whites Risk Prostate Cancer Recurrence Men who have an undergone prostate cancer treatment and are obese are found to be at risk for... more
- 08.13.09 - A Partial Approval for Amgen's Osteoporosis Drug Amgen's new bone drug, the company’s best hope for future growth, won a partial endorsement Thursday... more
- 08.11.09 - Oral Drug Ups Survival in Advanced Prostate Cancer Cases Oral sodium clodronate improves overall survival in advanced prostate cancer patients... more
- 08.11.09 - New Bone-Building Drug Promising Against Prostate Cancer A new bone-building drug has worked well in a trial of men whose bones were weakened... more
ZERO Multimedia
Sign Up for AWARE. Join our newsletter for important news and updates.